	Influenza vaccination after advanced acute kidney injury: effects on mortality, cardiovascular events, and pneumonia-a target trial emulation. Hypertens Res Liao HW, Cheng CY, Wang CA, Chen JY, Huang TM, Wu VC. PMID: 42115687 [PubMed - as supplied by publisher]
	Deep learning-based automatic field of view planning for prostate MRI in oblique coronal and oblique axial planes. Sci Rep Quinsten AS, Wetter A, Raczkowski M, Trembecki , Guz T, Oliveira S, Buchkremer R, Matusiewicz D, Nassenstein K, Forsting M, Demircio. PMID: 42115680 [PubMed - indexed for MEDLINE]
	Dissecting self-supervised learning strategies for transfer learning in MRI prostate cancer diagnosis. Sci Rep Facuse J, Campanini D, Parra D, Besa C, Salas R, Estévez PA, Mery D. PMID: 42115652 [PubMed - as supplied by publisher]
	Clinical profile and management outcomes of small renal masses: a collaborative multi-institutional Indian study led by the society of genitourinary oncologists. Int Urol Nephrol Sakthivel DK, Addla S, Pooleri GK, Raghunath SK, Tamhankar A, Sharma G, Gautam G, Singh A, Shah R, Rawal S, Ragavan N. PMID: 42115506 [PubMed - as supplied by publisher]
	Clinical outcomes of benign prostatic hyperplasia surgery in men with detrusor underactivity versus normal contractility: a systematic review and meta-analysis. Int Urol Nephrol Calvillo-Ramirez A, Esparza-Miranda LA, Casas-Huesca AP, Gutierrez HR, Hinojosa-Gonzalez DE, Khalil M, Sidana A. PMID: 42115505 [PubMed - as supplied by publisher]
	Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial. World J Urol Zhang X, Wu Z, Hao L, Qiu X, Xu L, Zhang S, Guo H, Zhuang J. PMID: 42115448 [PubMed - indexed for MEDLINE]
	The microbiome across the prostate disease continuum: from health and BPH to prostatitis/CPPS and cancer. Oncogene Cheng B, Gong L, Xu H, Wang Z, Huang H, Guan X, Wu P. PMID: 42115408 [PubMed - as supplied by publisher]
	Prolonged high-dose prenatal caffeine exposure induces organ-specific developmental toxicity: renal p53 downregulation and hepatic caspase-3 upregulation in neonatal mice, supported with in silico studies. Naunyn Schmiedebergs Arch Pharmacol Said A, Diab AA, Safwat G, AbdElkhalek AS, Kohela A, Alsedfy MY, Youssry M, Ahmed G, Nasraldin K. PMID: 42115392 [PubMed - as supplied by publisher]
	Selective autophagy in kidney health and disease. Nat Rev Nephrol Fu Y, Livingston MJ, Dong G, Chen A, Cai J, Dong Z. PMID: 42115354 [PubMed - as supplied by publisher]
	The evolution of prostate cancer grading: from Gleason score to risk taxonomy and the artificial intelligence revolution. Virchows Arch Munari E, Antonini P, Cima L, Polati R, Caliò A, Gobbo STM, Colecchia M, Netto GJ, Antonelli A, Bertolo RG, Grisi C, Litjens G, Brunelli M. PMID: 42115324 [PubMed - as supplied by publisher]
	Androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer: Molecular mechanisms and therapeutic strategies. Urol Oncol Li J, Wang X, Tang X. PMID: 42115122 [PubMed - as supplied by publisher]
	European Association of Urology Guidelines on Urethral Strictures: Summary of the 2026 Guidelines. Update in Recommendations for Endoluminal Management of Male Anterior Urethral Strictures. Eur Urol Campos-Juanatey F, Barratt R, Chan G, Dimitropoulos K, Esperto F, Greenwell TJ, Martins FE, Osman NI, Oszczudlowski M, Ploumidis A, Riechardt S, Verla W, Waterloos M, Bezuidenhout C, Lumen N. PMID: 42115120 [PubMed - as supplied by publisher]
	From Guillain-BarrÃ©-Like Neuropathy to EGPA: ANCA Testing and Kidney Biopsy as Diagnostic Turning Points. Nephrology (Carlton) Mancianti N, Guarnieri A, Donati G, Tripodi SA, Bardhi L, Battisti C, Salvo DP, Jingjing L, Conticini E, Cameli P, Garosi G. PMID: 42115108 [PubMed - indexed for MEDLINE]
	Clinical Trial Protocol for ProBio-mHSPC: A ctDNA-driven De-escalation and Intensification Platform Trial for Metastatic Hormone-sensitive Prostate Cancer. Eur Urol Focus De Laere B, Crippa A, Discacciati A, Mortezavi A, Müller C, Røder A, Rannikko A, Ost P, Eklund M, Lindberg J, Grönberg H, ProBio Investigators. PMID: 42115047 [PubMed - as supplied by publisher]
	Hyperfiltration in Critically Ill Older Adults: Incidence, Risk Factors, Time Course, and Predictive Performance of Kidney Function Estimation. Pharmacotherapy Mikami R, Imai S, Hayakawa M, Izumi G, Kashiwagi H, Sato Y, Nashimoto S, Wada T, Sugawara M, Takekuma Y. PMID: 42114995 [PubMed - indexed for MEDLINE]
	Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancer. J Immunother Cancer Aggarwal R, Zhang J, Monk P, Zhu X, Jones R, Linch M, Costin D, de Bono J, Karsh LI, Petrylak DP, Zhang L, Deshpande R, Borderies P, Huang J, O'Neill V, Donkor M, Tagawa S. PMID: 42114950 [PubMed - indexed for MEDLINE]
	Proteotoxicity and tubular epithelial cell fate in acute kidney injury: Molecular insights and treatment strategies. Life Sci Yerra VG, Gavara A, Paudel KR, Jeengar MK. PMID: 42114736 [PubMed - as supplied by publisher]
	Diffusion weighted MRI-based hypoxic fraction as a prognostic factor in the FLAME trial prostate cancer cohort. Radiother Oncol Guricová KM, van Houdt PJ, Salamanca MF, Schoots IG, Agrotis G, Draulans C, Haustermans K, Smeenk RJ, Kunze-Busch M, de Boer HCJ, van der Voort van Zyp JRN, Pos FJ, van der Heide UA. PMID: 42114601 [PubMed - as supplied by publisher]
	A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trial. Lancet Diabetes Endocrinol Zoungas S, D'Alessio D, Pavo I, Bhatt DL, Buse JB, Prato SD, Kahn SE, Lincoff AM, McGuire DK, Nauck MA, Nissen SE, Sattar N, Zinman B, Ceriello A, Stechemesser L, Verhaegen A, Broder JC, Wolfe R, Miller D, Nishiyama H, Wang X, Weerakkody G, Wiese RJ, Nicholls SJ. PMID: 42114520 [PubMed - as supplied by publisher]
	Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial. JCO Precis Oncol Armstrong AJ, Saad F, Oya M, Shore N, Procopio G, Arslan C, Mehra N, Brown E, Joung JY, Sugimoto M, Özgüro, Gedye C, Sartor O, Poehlein C, Qiu P, Liu YZ, Li X, Harrington EA, McGuinness D, Kang J, Barnicle A, Clarke N. PMID: 42114035 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 471673

Page 1 of 23584



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy